LSD1 ‐Demethylated LINC01134 Confers Oxaliplatin Resistance Through SP1 ‐Induced p62 Transcription in HCC-Reference-Cited by-同舟云学术

LSD1 ‐Demethylated LINC01134 Confers Oxaliplatin Resistance Through SP1 ‐Induced p62 Transcription in HCC

Published:2021-10-05 Issue:6 Volume:74 Page:3213-3234
ISSN:0270-9139
Container-title:Hepatology
language:en
Short-container-title:Hepatology

Author:

Ma Luyuan¹²^ORCID,Xu An³,Kang Lei⁴,Cong Rui²,Fan Zhongyi⁵,Zhu Xiang²,Huo Nan²,Liu Wenpeng¹,Xue Chunyuan²,Ji Quanbo⁶,Li Wenchao⁷,Chu Zhong²,Kang Xiaofeng²,Wang Yadong¹,Sun Zhijia²,Han Yuchen²,Liu Hanxiao²,Gao Xiang⁸,Han Juqiang⁷,You Hua⁹,Zhao Caiyan¹,Xu Xiaojie²

Affiliation:

1. Department of Infectious Diseases the Third Hospital of Hebei Medical University Shijiazhuang China

2. Department of Genetic Engineering Beijing Institute of Biotechnology Beijing China

3. Department of Oncology Second Medical Center of Chinese PLA General Hospital Beijing China

4. Department of Nuclear Medicine Peking University First Hospital Beijing China

5. Department of Oncology and Hematology Shenzhen Third People’s HospitalSecond Hospital Affiliated to Southern University of Science and Technology Shenzhen China

6. Department of Orthopedics First Medical Center of Chinese PLA General Hospital Beijing China

7. Seventh Medical Center of Chinese PLA General Hospital Beijing China

8. State Key Laboratory of Toxicology and Medical Countermeasures Beijing Institute of Pharmacology and Toxicology Beijing China

9. Department of Oncology Affiliated Cancer Hospital & Institute of Guangzhou Medical University Guangzhou China

Funder

National Natural Science Foundation of China

Publisher

Wiley

Subject

Hepatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/hep.32079

Reference37 articles.

1. Hepatic arterial infusion of oxaliplatin plus fluorouracil/leucovorin vs. sorafenib for advanced hepatocellular carcinoma

2. Ligand modulation of a dinuclear platinum compound leads to mechanistic differences in cell cycle progression and arrest

3. Curcumin Combined with Oxaliplatin Effectively Suppress Colorectal Carcinoma in vivo Through Inducing Apoptosis

4. ID1 promotes hepatocellular carcinoma proliferation and confers chemoresistance to oxaliplatin by activating pentose phosphate pathway

Cited by 45 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. HSP90a promotes the resistance to oxaliplatin in HCC through regulating IDH1-induced cell competition;Biochimica et Biophysica Acta (BBA) - Molecular Cell Research;2024-03

2. CAF-derived exosomal lncRNA FAL1 promotes chemoresistance to oxaliplatin by regulating autophagy in colorectal cancer;Digestive and Liver Disease;2024-02

3. Lysine-specific demethylase 1 as a therapeutic cancer target: observations from preclinical study;Expert Opinion on Therapeutic Targets;2023-12-02

4. ATR‐dependent ubiquitin‐specific protease 20 phosphorylation confers oxaliplatin and ferroptosis resistance;MedComm;2023-12

5. Integrating bulk and single-cell RNA sequencing data to establish necroptosis-related lncRNA risk model and analyze the immune microenvironment in hepatocellular carcinoma;Heliyon;2023-11